Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-07T05:21:51.248Z Has data issue: false hasContentIssue false

Preclinical activities of Cassia tora Linn against aging-related diseases

Published online by Cambridge University Press:  25 October 2022

Sun-Young Hwang
Affiliation:
College of Korean Medicine, Dongshin University, Naju 58245, Republic of Korea
Chang-Su Na
Affiliation:
College of Korean Medicine, Dongshin University, Naju 58245, Republic of Korea
Byeong Cheol Moon
Affiliation:
Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, Naju 58245, Republic of Korea
Jung-Hyun Shim*
Affiliation:
Department of Pharmacy, College of Pharmacy, Mokpo National University, Jeonnam 58554, Republic of Korea Department of Biomedicine, Health & Life Convergence Sciences, BK21 FOUR, Mokpo National University, Jeonnam 58554, Republic of Korea The China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, P.R. China
Mee-Hyun Lee*
Affiliation:
College of Korean Medicine, Dongshin University, Naju 58245, Republic of Korea
*
Authors for correspondence: Jung-Hyun Shim, E-mail: s1004jh@gmail.com, Mee-Hyun Lee, E-mail: mhlee@dsu.ac.kr (mhyun_lee@hanmail.net)
Authors for correspondence: Jung-Hyun Shim, E-mail: s1004jh@gmail.com, Mee-Hyun Lee, E-mail: mhlee@dsu.ac.kr (mhyun_lee@hanmail.net)
Rights & Permissions [Opens in a new window]

Abstract

Globally, an aging population is increasing, and aging is a natural physiological process and a major risk factor for all age-related diseases. It seriously threatens personal health and imposes a great economic burden. Therefore, there is a growing scientific interest in strategies for well-aging with prevention and treatment of age-related diseases. The seed, root, stem or leaves of Cassia tora Linn. are useful for anti-bacteria, anti-hyperlipidemia and anti-obesity due to its pharmacological activities such as anti-inflammation and anti-oxidant both in vitro and in vivo. Nevertheless, no clinical trials have been attempted so far, therefore here we would like to understand the current preclinical activities for aging-related disease models including cataract, metabolic dysfunction and neurodegeneration, then discuss their preparation for clinical trials and perspectives.

Information

Type
Review
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press
Figure 0

Fig. 1. An illustration of link between aging-related diseases and Cassia tora L. Aging changes pathological phenomena by induction of oxidative stresses and inflammatory responses thus causes to aging-related diseases including cataract, metabolic disease and neuronal disease, and Cassia tora Linn improves the diseases.

Figure 1

Fig. 2. Therapeutic effects of Cassia tora L. on aging-related diseases. Cassia tora L. exhibits pharmacological activities for anti-cataract, anti-metabolic disease, anti-neuronal disease and others including anti-malaria, anti-bacterial, and anti-allergy by depletion of oxidative stresses and inflammatory factors. MPO, myeloperoxidase; CCO 1, cytochrome c oxidase 1; ATP, adenosine triphosphate; Ube, ubiquitin-activating enzyme; NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells; Egr-1, early growth response protein 1; STAT6, signal transducer and activator of transcription 6; LTB4R, Leukotriene B4 Receptor; BDNF, brain derived neurotrophic factor; ROS, reactive oxygen species; COX-2, cyclooxygenase-2; DPPH, 2,2-diphenyl-1-picrylhydrazyl.

Figure 2

Table 1. Preclinical activities of Cassia tora L

Figure 3

Table 2. Components from different solvents and parts of Cassia tora